Dr Vidula on the Evaluation of Talazoparib in BRCA1/2-Mutated Metastatic Breast Cancer | OncLive
Dr Vidula on the Evaluation of Talazoparib in BRCA1/2-Mutated Metastatic Breast Cancer | OncLive
Jun 19, 2023
onclive.com
Dr Vaishampayan on the Use of Talazoparib and Enzalutamide in Patients With HRR Gene–Mutated mCRPC | OncLive
Dr Vaishampayan on the Use of Talazoparib and Enzalutamide in Patients With HRR Gene–Mutated mCRPC | OncLive
Aug 24, 2023
onclive.com
TALAVE: induction talazoparib with PARP inhibition in breast cancer
2:47
TALAVE: induction talazoparib with PARP inhibition in breast cancer
350 viewsMay 3, 2023
YouTubeVJOncology
タルゼンナ（タラゾパリブ）の副作用、相互作用、使用および薬物の刷り込み - 健康 2026
タルゼンナ（タラゾパリブ）の副作用、相互作用、使用および薬物の刷り込み - 健康 2026
Aug 22, 2019
oldmedic.com
Cancer Clinical Trial That Combines Three Chemotherapy Drugs
2:25
Cancer Clinical Trial That Combines Three Chemotherapy Drugs
311 viewsDec 28, 2016
YouTubeUW Health
Dr. Yardley Discusses Data With Talazoparib in Breast Cancer
1:50
Dr. Yardley Discusses Data With Talazoparib in Breast Cancer
1K viewsAug 27, 2018
YouTubeOncLive
ASCO25: Atish Choudhury, MD, PhD Talazoparib + Tazemetostat | Dana-Farber Cancer Institute
2:23
ASCO25: Atish Choudhury, MD, PhD Talazoparib + Tazemetostat | Dana-Farber Cancer Institute
96 views10 months ago
YouTubeDana-Farber Cancer Institute
1:20
In our latest “Science in Seconds,” Dr. Bradley McGregor discusses two findings from the phase 3 TALAPRO-2 trial highlighting final overall survival with talazoparib (TALA) enzalutamide (ENZA) as first-line treatment: one for unselected patients with metastatic castration-resistant prostate cancer (mCRPC) and one for patients with homologous recombination repair (HRR)-deficient #mCRPC. #GU25 https://brnw.ch/21wQFX7 https://brnw.ch/21wQFX6 | American Society of Clinical Oncology
216 viewsFeb 13, 2025
FacebookAmerican Society of Clinical Oncology
0:22
PARP Inhibitors Stops Cancer Cells from Repairing? Olaparib Explained!
6.5K views9 months ago
YouTubeYerbba – Breast Cancer
2:02
Dr. Litton on a Study of Neoadjuvant Talazoparib for Patients With BRCA-Mutated TNBC
200 viewsDec 5, 2018
YouTubeOncLive
0:56
David Cameron reveals prostate cancer diagnosis
3 months ago
The IndependentStorm Newton
4:40
Talazoparib Improves Overall Survival in Metastatic CRPC
Mar 13, 2025
medpagetoday.com
4:01
oncotutos®_TALAZOPARIB - TALZENNA®
7 months ago
VimeoCommunication SFPO
24:28
عقار يجبر الخلايا السرطانية على الموت
Oct 16, 2021
aljazeera.net
2:10
转移性去势抵抗性前列腺癌 他拉唑帕利联合恩扎卢胺的远期OS改善显著
2 views3 weeks ago
bilibili肿瘤科普工坊
ASCO® 2023 Insights: "Use of ctDNA to Complement Tumor Tissue HRR Gene Alteration Testing in TALAPRO-2, A Phase 3 Study of Talazoparib Enza vs. Placebo Enza as 1L Treatment for mCRPC"
37 viewsJun 20, 2023
vumedi.com
7:41
ASCO 2020: "PARP-Inhibitor (Olaparib und Talzoparib), wann für wen?", Prof. Janni
2.1K viewsJun 2, 2020
YouTubeBrustkrebs Deutschland e.V.
1:02
Dr. Agarwal on the Safety Profile of Enzalutamide/Talazoparib in mCRPC
706 viewsOct 7, 2019
YouTubeOncLive
1:54
Phase I/Ib trial of talazoparib plus gemtuzumab ozogamicin in R/R AML
87 viewsDec 6, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:03
他拉帕唑利的功效与作用
2 weeks ago
bilibili抗癌驿站
5:01
Talazoparib plus enzalutamide shows improvement in PFS over SOC in first-line HRR mCRPC
410 viewsJul 7, 2023
YouTubeecancer
6:52
ASCO 2021: Früher Brustkrebs neoadjuvant: Talazoparib bei triple-negativer BRCA 1/2 Keimbahnmutation
863 viewsJun 11, 2021
YouTubeBrustkrebs Deutschland e.V.
4:02
Talazoparib – TALZENNA®
100 viewsMar 1, 2024
YouTubeOncotutos SFPO
7:35
TALAPRO-2 and First-Line mCRPC Treatment: Insights on OS Benefits and Treatment Sequencing
430 viewsMar 5, 2025
YouTubeGU Oncology Now
25:23
AGO 2021: Metastasierter Brustkrebs: Zielgerichtete Therapie, Prof. Jackisch und Prof. Schmidt
1.1K viewsMar 2, 2021
YouTubeBrustkrebs Deutschland e.V.
Pfizer Reports Positive Results in Prostate Cancer Study
1 month ago
marketscreener.com
14:39
New FDA Approved PARP Inhibitor: Talzenna (Talazoparib) & Xtandi | #markscholzmd #AlexScholz #pcri
13.3K viewsJul 17, 2023
YouTubeProstate Cancer Research Institute
Thuốc mới điều trị ung thư tiền liệt tuyến giai đoạn cuối
Sep 6, 2021
suckhoedoisong.vn
0:12
Lauren on Instagram: "Not 👏 A 👏 Fad ! 👏 Notice these trials are all using tirzepatide ?! There are active and recently opened clinical/human trials (& more coming !) testing tirzepatide in breast-cancer populations. Why ? Because 🐁 models have been so encouraging ! What can Tirzep do ? 1. Lowers inflammation 2. Reduces joint pain 3. Improves heart health. 4. Improves liver and metabolic health. 5. Reduces hot flashes. 6. Creates a less growth-permissive metabolic environment for bad cells !
50.3K views5 months ago
Instagramohheybreastie
28:25
Episode 367: Pharmacology 101: PARP Inhibitors
227 views10 months ago
YouTubeOncology Nursing Society
See more